Apelin Receptor (APLNR) Peptide
APLNR
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN940165
Quick Overview for Apelin Receptor (APLNR) Peptide (ABIN940165)
Target
Apelin Receptor (APLNR)
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- LAKLKKKKGP STVTDLEDTK RDRSVDVNGG PEPAPASTSA VSTPSPSADL
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of APLNR antibody,
Alternative Names: APLNR control peptide, APLNR antibody Blocking Peptide, Anti-APLNR Blocking Peptide, apelin receptor Blocking Peptide, AGTRL1 Blocking Peptide, APJ Blocking Peptide, APJR Blocking Peptide, FLJ90771 Blocking Peptide, FLJ96609 Blocking Peptide, HG11 Blocking Peptide, MGC45246 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- Apelin Receptor (APLNR)
-
Background
- This gene encodes a member of the G protein-coupled receptor gene family. The encoded protein is related to the angiotensin receptor, but is actually an apelin receptor that inhibits adenylate cyclase activity and plays a counter-regulatory role against the pressure action of angiotensin II by exerting hypertensive effect. It functions in the cardiovascular and central nervous systems, in glucose metabolism, in embryonic and tumor angiogenesis and as a human immunodeficiency virus (HIV-1) coreceptor. Two transcript variants resulting from alternative splicing have been identified.
-
Molecular Weight
- 104 kDa
Target
-
You are here:
